Track Dishman Carbogen Amcis Limited — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Dishman Carbogen Amcis Limited DCAL.NS Open Dishman Carbogen Amcis Limited in new tab

147.50 INR
P/E
17.15
EPS
7.58
P/B
0.32
ROE
2.25
Beta
0.16
Loading chart...
Key Metrics
Earnings dateMay 19, 2026
P/E17.15
EPS7.58
Book Value405.67
Price to Book0.32
Debt/Equity40.20
% Insiders69.303%
Growth
Revenue Growth0.06%
Earnings Growth0.97%
Estimates
Forward P/E10.40
Forward EPS12.50

DCF Valuation

Tweak assumptions to recompute fair value for Dishman Carbogen Amcis Limited (DCAL.NS)
Currency: INR
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Dishman Carbogen Amcis Limited Logo Dishman Carbogen Amcis Limited Analysis (DCAL.NS)

India Health Care Official Website Stock

Is Dishman Carbogen Amcis Limited a good investment? Dishman Carbogen Amcis Limited (DCAL.NS) is currently trading at 147.50 INR.

In terms of valuation, the stock trades at a P/E ratio of 17.15. This valuation is generally in line with the broader market.

Earnings Schedule: Dishman Carbogen Amcis Limited is expected to release its next earnings report on May 19, 2026. The market consensus estimate for Forward EPS is 12.50.

Investor FAQ

Does Dishman Carbogen Amcis Limited pay a dividend?

No, it does not currently pay a dividend.

What asset class is Dishman Carbogen Amcis Limited?

Dishman Carbogen Amcis Limited is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be May 19, 2026. The company currently has a trailing EPS of 7.58.

Company Profile

Dishman Carbogen Amcis Limited provides contract research and manufacturing services for the pharmaceutical and healthcare industries worldwide. The company operates through Contract Research and Manufacturing Services and Marketable Molecules segments. It offers cholesterol and vitamin D analogs; generic active pharmaceutical ingredients for diagnostics, ophthalmic treatments, laxatives, organophosphate antidotes; ammonium, phosphonium; quats, phosphoranes, and wittig reagents; cholesterol and lanolin-related products; sterile injectables; and softgel formulations, as well as hand and body wash, sanitisers, and antiseptics. The company was founded in 1983 and is headquartered in Ahmedabad, India. Dishman Carbogen Amcis Limited is a subsidiary of Adimans Technologies LLP.

Exchange Ticker
NSI (India) DCAL.NS
Historical Dividends
Year Total Dividends
2019 0.20 INR
2017 1.20 INR
2016 2.00 INR
2015 2.00 INR
2014 1.20 INR
2013 1.20 INR
2012 1.20 INR
2011 1.20 INR
2010 1.20 INR
2009 1.20 INR
2008 1.00 INR
2007 1.00 INR
2006 0.70 INR
2005 2.50 INR
2004 2.00 INR

Yearly aggregated dividends

Dividends

Historical Split Corporate Actions

Split Date Split Ratio to 1
Oct. 21, 2005 5.000000
May 2, 2016 2.000000
Trades
Trade History
No trades yet
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion